176 related articles for article (PubMed ID: 35795714)
1. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
EClinicalMedicine; 2022 Aug; 50():101527. PubMed ID: 35795714
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
Stephenson MD; Kutteh WH; Purkiss S; Librach C; Schultz P; Houlihan E; Liao C
Hum Reprod; 2010 Sep; 25(9):2203-9. PubMed ID: 20634190
[TBL] [Abstract][Full Text] [Related]
4. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
[TBL] [Abstract][Full Text] [Related]
5. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial.
Christiansen OB; Larsen EC; Egerup P; Lunoee L; Egestad L; Nielsen HS
BJOG; 2015 Mar; 122(4):500-8. PubMed ID: 25412569
[TBL] [Abstract][Full Text] [Related]
7. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
van Dijk MM; Vissenberg R; Fliers E; van der Post JAM; van der Hoorn MP; de Weerd S; Kuchenbecker WK; Hoek A; Sikkema JM; Verhoeve HR; Broeze KA; de Koning CH; Verpoest W; Christiansen OB; Koks C; de Bruin JP; Papatsonis DNM; Torrance H; van Wely M; Bisschop PH; Goddijn M
Lancet Diabetes Endocrinol; 2022 May; 10(5):322-329. PubMed ID: 35298917
[TBL] [Abstract][Full Text] [Related]
10. Chinese herbal medicines for unexplained recurrent miscarriage.
Li L; Dou L; Leung PC; Chung TK; Wang CC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010568. PubMed ID: 26760986
[TBL] [Abstract][Full Text] [Related]
11. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
Coulam CB; Krysa L; Stern JJ; Bustillo M
Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
[TBL] [Abstract][Full Text] [Related]
13. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
[TBL] [Abstract][Full Text] [Related]
14. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
Subtil D; Brabant G; Tilloy E; Devos P; Canis F; Fruchart A; Bissinger MC; Dugimont JC; Nolf C; Hacot C; Gautier S; Chantrel J; Jousse M; Desseauve D; Plennevaux JL; Delaeter C; Deghilage S; Personne A; Joyez E; Guinard E; Kipnis E; Faure K; Grandbastien B; Ancel PY; Goffinet F; Dessein R
Lancet; 2018 Nov; 392(10160):2171-2179. PubMed ID: 30322724
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
Hoffman MK; Goudar SS; Kodkany BS; Metgud M; Somannavar M; Okitawutshu J; Lokangaka A; Tshefu A; Bose CL; Mwapule A; Mwenechanya M; Chomba E; Carlo WA; Chicuy J; Figueroa L; Garces A; Krebs NF; Jessani S; Zehra F; Saleem S; Goldenberg RL; Kurhe K; Das P; Patel A; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Liechty EA; Goco N; Hemingway-Foday J; Moore J; Nolen TL; McClure EM; Koso-Thomas M; Miodovnik M; Silver R; Derman RJ;
Lancet; 2020 Jan; 395(10220):285-293. PubMed ID: 31982074
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
Nørgaard-Pedersen C; Nielsen K; Steffensen R; Eriksen L; Jørgensen MM; Kesmodel US; Christiansen OB
BMJ Open; 2022 Sep; 12(9):e064780. PubMed ID: 36137638
[TBL] [Abstract][Full Text] [Related]
18. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial.
Stephenson MD; Dreher K; Houlihan E; Wu V
Am J Reprod Immunol; 1998 Feb; 39(2):82-8. PubMed ID: 9506206
[TBL] [Abstract][Full Text] [Related]
19. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage.
Christiansen OB; Pedersen B; Rosgaard A; Husth M
Hum Reprod; 2002 Mar; 17(3):809-16. PubMed ID: 11870141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
